News & Media: All

Aug 18, 2014

Philipson in Forbes: "A Dangerous Race To The Bottom In Biotechnology"

Tomas Philipson's latest Forbes.com commentary examines the current debate surrounding whether to allow differential naming of similar biologic products. What if Coke and Pepsi were forced to call their product "Copsi?"

To read the complete commentary, please click here.

Aug 15, 2014

PHE's MacEwan Featured in London School of Economics Policy Blog

PHE economist Joanna MacEwan and coauthor's recent publication on the public cost of obesity in the U.S. was featured on the London School of Economics and Political Science's policy blog: “Obesity imposes a burden of over $166 billion on Medicare and Medicaid in the United States.”

To vi ...

Aug 8, 2014

Dana Goldman Featured in New Film: "The Healthspan Imperative"

PHE Founding Partner Dana Goldman is featured in a new film produced by the The Alliance for Aging Research, entitled "The Healthspan Imperative." Featuring narration from Martha Stewart, the film focuses on the so-called "Silver Tsunami" of baby boomers now reaching retirement age, and the impl ...

Jul 23, 2014

Join PHE Partner Dana Goldman for WSJ Live Twitter Chat on Tuesday, July 29th

We invite you to join PHE Founding Partner Dana Goldman as he live tweets in association with The Wall Street Journal and its Pharmalot blog, moderated by Ed Silverman. The live tweet session will commence at 5pm PDT on July 29th-- just use #pharmalotchat to join the session. The focus of this l ...

Jul 10, 2014

Philipson In Forbes: "Reward Innovation"

PHE Partner Tomas Philipson's latest Op-Ed in Forbes (with his co-author, PHE Senior Principal Consultant and former FDA Chairman Andrew von Eschenbach): "Innovation Needs To Be Rewarded"

READ THE ARTICLE

Jun 9, 2014

PHE's Amitabh Chandra in NY Times: "How To Pay For Only The Health Care You Want"

PHE's Chief Scientific Officer Amitabh Chandra, along with his co-author Austin Frakt, contribute a new commentary in the New York Times: "How To Pay For Only The Health Care You Want."

To read the complete article, please click here.

Jun 6, 2014

Philipson in Forbes: "Scapegoating Shinseki Will Not Solve The Problem"

Tomas Philipson's latest Forbes.com Op-Ed points out the underlying problem facing the Veteran Health Administration.

To read the complete commentary, please click here.

May 26, 2014

Find PHE At ISPOR 2014: Booth 62/63/78/79

Look for PHE at ISPOR Montreal, with posters and presentations defining the health care economics discussion, including the latest perspective on the ACA:

POSTER SESSION III – PRS60

Tuesday, June 3rd | Location: R2

Poster Display Hours: 8:30am-2:15pm, Author Discussion: 1:15pm-2:15pm

“Th ...

May 25, 2014

PHE's Chandra and Sood Cited in Obama's 2014 Economic Report of the President

For the second consecutive year, PHE has been cited in Obama's Economic Report of the President. PHE Chief Scientific Advisor Amitabh Chandra and Principal Consultant Neeraj Sood were both cited in the recently released 2014 Economic Report of the President.

Dr. Chandra was cited several times ...

May 13, 2014

An Economic Giant Departs: Gary Becker 1930-2014

Tomas Philipson pays tribute to colleague and Nobel Prize winning economics pioneer Gary Becker in a special Forbes.com column.

Read the tribute here.

May 7, 2014

Philipson in Forbes: The High Cost of Medical Innovation

In his monthly Forbes.com commentary, Tomas Philipson examines why raising capital for medical R & D is abnormally expensive.

Read the column here.

Apr 14, 2014

PHE Opens Fifth Office In Austin, Texas

Precision Health Economics is proud to announce the opening of its fifth location—Austin, TX—as part of its continuing expansion plan.  The Austin office will house both research and executive administrative functions. PHE will draw on the city's fertile recruitment pool of highly educated ...

Apr 11, 2014

Philipson Participates in PhRMA Annual Meeting Innovation Discussion

PHE Partner Tomas Philipson participated in PhRMA's 56th Annual meeting held on April 9th, 2014 in Washington, DC-- offering his perspective as a panelist. The panel topic, "The Value of Medical Innovation to Patients, Economies and Society" featured commentary from Dr. Philipson as well as seve ...

Apr, 2014

Forbes April Op-Ed by Tomas Philipson and Dana Goldman: Health Insurance "Double Jeopardy"

PHE partners Tomas Philipson and Dana Goldman team up for their latest Forbes. com Op-Ed: "'Double Jeopardy' in American Health Insurance."

To read the complete article, please click here.

Mar 31, 2014

PHE Taps BMS Executive Ross Maclean As Chief Operating Officer

Precision Health Economics is proud to announce the hiring of Ross Maclean as our chief operating officer (COO). Dr. Maclean's significant and varied background spans the provider, payer, and manufacturing worlds in multiple countries, encompassing leadership skills, management talents, and a ra ...

Mar 28, 2014

PHE Study Cited in US News & World Report

PHE's recent study on the influence of nutritional supplements in hospital readmissions was cited in Robert Miller's Op-Ed for US News & World Report: "Is Nutrition the First Step in Addressing Hospital Readmissions?"

To read the complete article, please click here.

Mar 13, 2014

Goldman In Forbes: Obamacare Not Responsible For Deceleration of Health Care Spending

Dana Goldman and his co-author Sarah Axeen contribute to Forbes.com with "No, Obamacare Isn't Responsible for The Deceleration of US Health Care Spending."

To read the complete article, click here.

Mar 12, 2014

PHE Authors Key Contributors To Health Affairs' HIV Edition

Precision Health Economics authors are prominently featured in the March 2014 edition of Health Affairs, focusing on the ACA and Vulnerable Americans. Seven articles published in the journal feature PHE authors, including:

  • "Early HIV Treatment in The United States Prevented Nearly 13,500 Infe ...

Mar 10, 2014

Philipson Contributes To Special Scientific American Cancer Supplement

Founding Partner Tomas Philipson is a contributor to Scientific American's just-released special cancer supplement: "A World Free From Cancer." Dr. Philipson's perspective is featured in "The Price of Progress: Do the benefits justify the cost?"

To download a complete .pdf copy of the supplemen ...

Mar 6, 2014

PHE's Lakdawalla Appears Before California State Assembly Hearing on Biotechnology

PHE Founding Partner Darius Lakdawalla recently appeared before the California State Assembly, as part of a special hearing on Biotechnology.

Video of Dr. Lakdawalla's testimony is now available online via YouTube and iTunes U. To view please click on the links below:

For iTunes U video, plea ...

Mar 5, 2014

PHE's Philipson and von Eschenbach in Forbes: "Can FDA Be A Life-Boat?"

Tomas Philipson and his co-author, ex-FDA Commissioner Andrew von Eschenbach (currently a Senior Principal Consultant at PHE) contribute their perspective in March's Forbes.com commentary: "The Coming Perfect Storm In Medical Innovation: Can FDA Be A Life-Boat?"

To read the complete commentary, ...

Mar 4, 2014

New York Times Commentary Cites PHE's Philipson

PHE partner Tomas Philipson is cited in this New York Times Commentary by Casey B. Mulligan, Dr. Philipson's colleague at the University of Chicago. The Op-Ed: "The Economics of Randomized Experiments," references Dr. Philipson's suggestions regarding the incentives offered to participants in cl ...